Intravenous paclitaxel is specifically retained in human gynecologic carcinoma tissues in vivo - Koshiba, H; Hosokawa, K; Mori, T; Kubo, A; Watanabe, A; Honjo, H (Int J Gynecol Cancer, 2009)